Luye Pharma Group Ltd (2186.HK)
Company Info
Highlights
HK$7.34B
15.00
HK$1.67 - HK$3.75
HK$2.52
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Luye Pharma Group Ltd (2186.HK) returned -10.14% year-to-date (YTD) and -36.07% over the past 12 months. Over the past 10 years, 2186.HK returned -14.23% annually, underperforming the S&P 500 benchmark at 10.46%.
2186.HK
-10.14%
9.55%
-31.58%
-36.07%
-12.77%
-14.23%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 2186.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -3.23% | 11.43% | -8.12% | -6.05% | -3.47% | -10.14% | |||||||
| 2024 | -29.49% | 9.89% | -5.54% | 1.47% | -3.25% | 0.75% | 3.33% | 9.32% | 9.84% | -16.72% | -9.68% | -13.89% | -41.82% |
| 2023 | 9.84% | -10.20% | 0.83% | 5.77% | -9.35% | -5.16% | 9.97% | -20.88% | 21.88% | 7.98% | 2.90% | -4.36% | 1.91% |
| 2022 | -4.78% | -7.08% | -4.76% | -17.67% | -0.40% | 4.88% | -8.91% | -3.40% | -3.96% | -12.39% | 59.16% | 20.39% | 2.81% |
| 2021 | 7.76% | 34.70% | -5.15% | -5.03% | 17.16% | -7.59% | -18.20% | -0.72% | -1.93% | -8.85% | -3.50% | -0.56% | -1.39% |
| 2020 | -13.70% | -5.75% | -20.42% | 0.00% | 2.38% | 23.96% | 3.16% | -14.11% | 7.14% | -0.44% | 0.89% | -20.13% | -37.44% |
| 2019 | 6.97% | 0.51% | 17.06% | 3.50% | -16.90% | -2.94% | 7.95% | -0.33% | -7.21% | 3.93% | -1.03% | 1.57% | 9.60% |
| 2018 | 13.29% | -3.00% | 10.77% | 11.58% | 2.74% | -5.92% | -5.22% | -3.15% | -4.29% | -13.82% | 3.14% | -12.66% | -10.44% |
| 2017 | 11.74% | -1.17% | -7.48% | 0.00% | -0.21% | -7.94% | 3.50% | -10.61% | 15.15% | 14.86% | -0.58% | 19.34% | 36.29% |
| 2016 | -20.79% | -2.34% | -4.00% | -10.00% | -11.11% | -1.04% | 5.89% | -1.99% | 3.04% | 3.49% | -0.38% | -11.54% | -42.66% |
| 2015 | -7.21% | -1.83% | 2.97% | 6.30% | -15.26% | -1.66% | -2.41% | -18.52% | 4.39% | 11.03% | -11.76% | 19.70% | -19.12% |
| 2014 | 0.60% | 26.85% | 16.37% | 12.56% | -8.93% | -2.06% | 49.10% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 2186.HK is 18, meaning it’s performing worse than 82% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Luye Pharma Group Ltd (2186.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Luye Pharma Group Ltd provided a 0.00% dividend yield over the last twelve months, with an annual payout of HK$0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.13 | HK$0.11 | HK$0.07 | HK$0.04 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.66% | 2.26% | 1.93% | 1.17% | 0.80% |
Monthly Dividends
The table displays the monthly dividend distributions for Luye Pharma Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 | HK$0.00 | HK$0.00 | HK$0.07 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.13 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.03 | HK$0.00 | HK$0.00 | HK$0.07 |
| 2016 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.04 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Luye Pharma Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Luye Pharma Group Ltd was 83.06%, occurring on Apr 9, 2025. The portfolio has not yet recovered.
The current Luye Pharma Group Ltd drawdown is 81.33%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -83.06% | Oct 31, 2014 | 2568 | Apr 9, 2025 | — | — | — |
| -6.9% | Sep 22, 2014 | 11 | Oct 8, 2014 | 15 | Oct 29, 2014 | 26 |
| -5.72% | Jul 23, 2014 | 6 | Jul 30, 2014 | 4 | Aug 5, 2014 | 10 |
| -3.2% | Aug 6, 2014 | 2 | Aug 7, 2014 | 11 | Aug 22, 2014 | 13 |
| -2.93% | Sep 3, 2014 | 2 | Sep 4, 2014 | 3 | Sep 10, 2014 | 5 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Luye Pharma Group Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Luye Pharma Group Ltd, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Luye Pharma Group Ltd is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 2186.HK, comparing it with other companies in the Drug Manufacturers - General industry. Currently, 2186.HK has a P/E ratio of 15.0. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 2186.HK relative to other companies in the Drug Manufacturers - General industry. Currently, 2186.HK has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 2186.HK in comparison with other companies in the Drug Manufacturers - General industry. Currently, 2186.HK has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |